Computational development of rubromycin-based lead compounds for HIV-1 reverse transcriptase inhibition

Bernardo, Carlos E. P.; Silva, Pedro J.

http://hdl.handle.net/10284/5213

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
peerj-470.pdf		5.83 MB	Adobe PDF	Download

Send Feedback

Authors

Bernardo, Carlos E. P.

Silva, Pedro J.

Abstract(s)

The binding of several rubromycin-based ligands to HIV1-reverse transcriptase was analyzed using molecular docking and molecular dynamics simulations. MM-PBSA analysis and examination of the trajectories allowed the identification of several promising compounds with predicted high affinity towards reverse transcriptase mutants which have proven resistant to current drugs. Important insights on the complex interplay of factors determining the ability of ligands to selectively target each mutant have been obtained.

Keywords

Molecular dynamics Docking Computer-aided drug design

URI

http://hdl.handle.net/10284/5213

Citation

Bernardo CEP, Silva PJ. (2014). Computational development of rubromycin-based lead compounds for HIV-1 reverse transcriptase inhibition. PeerJ – Life and Environment : DOI 10.7717/peerj.470. ISSN 2167-8359.